Artificial Intelligence

MindRank in Phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%

0

Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its weight-loss drug, making it China’s first artificial…

Read More